FFCP PHASE1:Mm9::chr3:106022395..106022401,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=104183 | |EntrezGene=104183 | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=3 | |||
|TSSclassifier=NA | |||
|UniProt=Q3V2C9,Q91Z98,Q61201 | |UniProt=Q3V2C9,Q91Z98,Q61201 | ||
|association_with_transcript=0bp_to_NM_145126,uc008qvx.2_5end | |association_with_transcript=0bp_to_NM_145126,uc008qvx.2_5end | ||
|cluster_id=chr3:106022395..106022401,- | |||
|description=CAGE_peak_1_at_Chi3l4_5end | |description=CAGE_peak_1_at_Chi3l4_5end | ||
|id=chr3:106022395..106022401,- | |id=chr3:106022395..106022401,- | ||
|ontology_enrichment_celltype=CL:0000553!3.55e-12!6;CL:0000556!3.55e-12!6;CL:0000355!7.28e-09!9;CL:0000050!2.56e-08!9;CL:0000414!6.62e-07!11;CL:0000049!7.60e-07!19 | |ontology_enrichment_celltype=CL:0000553!3.55e-12!6;CL:0000556!3.55e-12!6;CL:0000355!7.28e-09!9;CL:0000050!2.56e-08!9;CL:0000414!6.62e-07!11;CL:0000049!7.60e-07!19 | ||
|ontology_enrichment_celltype_v019_2=CL:0000355,2.36e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!2.56e-25!3;DOID:4045!2.56e-25!3;DOID:0050686!5.27e-13!6 | |ontology_enrichment_disease=DOID:0060100!2.56e-25!3;DOID:4045!2.56e-25!3;DOID:0050686!5.27e-13!6 | ||
|ontology_enrichment_disease_v019_2=DOID:0060100,3.27e-44,3;DOID:4045,3.27e-44,3;DOID:0050686,1.35e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!7.28e-09!9;UBERON:0002036!7.28e-09!9;UBERON:0002385!7.28e-09!9;UBERON:0000486!7.28e-09!9;UBERON:0001015!7.28e-09!9;UBERON:0004290!7.28e-09!9;UBERON:0003082!7.28e-09!9;UBERON:0002204!8.32e-09!32;UBERON:0000383!4.95e-08!10;UBERON:0002329!2.39e-07!11;UBERON:0003077!2.39e-07!11;UBERON:0003059!2.39e-07!11;UBERON:0007282!2.39e-07!11;UBERON:0009618!2.39e-07!11;UBERON:0007285!2.39e-07!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.36e-15,9;UBERON:0002036,2.36e-15,9;UBERON:0002385,2.36e-15,9;UBERON:0000486,2.36e-15,9;UBERON:0007503,2.36e-15,9;UBERON:0001015,2.36e-15,9;UBERON:0002329,2.36e-15,9;UBERON:0003082,2.36e-15,9;UBERON:0003059,2.36e-15,9;UBERON:0007282,2.36e-15,9;UBERON:0004290,2.36e-15,9;UBERON:0009618,2.36e-15,9;UBERON:0000383,6.72e-14,10;UBERON:0007524,1.04e-12,11;UBERON:0003077,1.04e-12,11;UBERON:0007285,1.04e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202475267389826,0,0.157731082679119,0.274228867211478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.6709866446347,28.9094077473806,22.5115209908733,12.9410927366823,20.4913645487534,23.3044969454954,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.599902730993408,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202475267389826,0,0.157731082679119,0.274228867211478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.6709866446347,28.9094077473806,22.5115209908733,12.9410927366823,20.4913645487534,23.3044969454954,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.599902730993408,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p1@Chi3l4 | |short_description=p1@Chi3l4 | ||
}} | }} |
Latest revision as of 06:17, 27 September 2015
Short description: | p1@Chi3l4 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_1_at_Chi3l4_5end |
Coexpression cluster: | MCL_coexpression_mm9:3 |
Association with transcript: | 0bp_to_NM_145126, uc008qvx.2_5end |
EntrezGene: | Chi3l4 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 2.36e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 2.36e-15 | 9 |
striated muscle tissue | 2.36e-15 | 9 |
muscle tissue | 2.36e-15 | 9 |
multilaminar epithelium | 2.36e-15 | 9 |
epithelial vesicle | 2.36e-15 | 9 |
musculature | 2.36e-15 | 9 |
somite | 2.36e-15 | 9 |
myotome | 2.36e-15 | 9 |
presomitic mesoderm | 2.36e-15 | 9 |
presumptive segmental plate | 2.36e-15 | 9 |
dermomyotome | 2.36e-15 | 9 |
trunk paraxial mesoderm | 2.36e-15 | 9 |
musculature of body | 6.72e-14 | 10 |
dense mesenchyme tissue | 1.04e-12 | 11 |
paraxial mesoderm | 1.04e-12 | 11 |
presumptive paraxial mesoderm | 1.04e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 3.27e-44 | 3 |
muscle cancer | 3.27e-44 | 3 |
organ system cancer | 1.35e-22 | 6 |